Development and Validation of an HPLC-UV Method for the Quantification of Acyclovir and Ganciclovir in the Plasma of Pediatric Immunocompromised Patients
Acyclovir and ganciclovir comprise the prophylaxis and treatment of herpesvirus and cytomegalovirus infections occurring in immunocompromised patients. Their therapeutic drug monitoring is fundamental because of interindividual variability leading to side effects and drug resistance and is performed...
Main Authors: | Martina Franzin, Rachele Ruoso, Rossella Del Savio, Riccardo Addobbati |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/5/2685 |
Similar Items
-
Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1
by: Phu Hoang Anh Nguyen, et al.
Published: (2024-01-01) -
In vitro activity of six antiviral drugs against equid alphaherpesvirus type 1 indicates ganciclovir as promising drug for in vivo studies
by: Amanda Lovato de Oliveira, et al.
Published: (2018-12-01) -
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
by: Lauren A. Sadowski, et al.
Published: (2021-06-01) -
Antiviral Drugs for EBV
by: Joseph S. Pagano, et al.
Published: (2018-06-01) -
Acute Kidney Injury in the ICU during Ganciclovir Treatment, an Observational Study
by: Mina Al Fartousi, et al.
Published: (2023-02-01)